Results 11 to 20 of about 22,090 (255)
Intraocular pressure variability in patients who reached target intraocular pressure [PDF]
British Journal of Ophthalmology, 2005 To assess the intraocular pressure (IOP) variability in patients with primary open angle glaucoma (POAG) under clinical treatment who reached an established target pressure based on isolated office readings.Retrospective analysis of 65 eyes from 65 POAG patients under clinical therapy who submitted to modified diurnal tension curve (mDTC) (measurements
F K, Malerbi +3 more
openaire +2 more sources
CORRELATIONS BETWEEN SUCCESSFUL THERAPY AND ANXIETY LEVEL OF POST OPERATIVE GLAUCOMA PATIENTS
Jurnal Kedokteran Diponegoro, 2020 Background : Glaucoma is a disease that can cause damage to the optic nerve. High intraocular pressure is a major risk factor for glaucoma. The main goal of treating glaucoma is to control the disease progression by reducing intraocular pressure to the ...
Singgih Pratama +3 more
doaj +1 more source
Intraocular pressure reduction in glaucoma: Does every mmHg count?
Taiwan Journal of Ophthalmology, 2020 The reduction of intraocular pressure is currently the only known modifiable risk factor for the treatment of Glaucoma, which is the leading cause of irreversible worldwide blindness.
Hari Jayaram
doaj +1 more source
Therapeutic Advances in Ophthalmology, 2021 Purpose: To evaluate the long-term effectiveness of iTrack (Nova Eye Medical, Fremont, USA) ab-interno canaloplasty performed as a standalone procedure, or combined with cataract surgery, in reducing antiglaucoma medication dependence and maintaining ...
Mahmoud A. Khaimi
doaj +1 more source
Pharmacodynamic equivalence study of two preparations of eye drops, containing dorzolamide in healthy volunteers [PDF]
Hospital Pharmacology, 2016 Introduction: Dorzolamide 20mg/ml eye drops (dorzolamide hydrochloride (CAS: 120279-96-1)) is a topical carbonic anhydrase inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular ...
Gatchev Emil M. +6 more
doaj +1 more source
BMC Ophthalmology, 2012 Background To determine the agreement between intraocular pressure and the ‘Wuerzburg bleb classification score’, as well as between single items of the score and intraocular pressure. Interobserver variability was analyzed.
Furrer Sandra +3 more
doaj +1 more source
Personalizing Intraocular Pressure
Asia-Pacific Journal of Ophthalmology, 2016 Determining target intraocular pressure (IOP) in glaucoma patients is multifaceted, requiring attention to many different factors such as glaucoma type, severity of disease, age, race, family history, corneal thickness and hysteresis, and initial IOP.
Arthur J, Sit, Christopher M, Pruet
openaire +2 more sources
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Cells, 2021 Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual information to the brain. Currently, the only available therapies target the lowering of
James R. Tribble +6 more
doaj +1 more source
Target intraocular pressure in the management of glaucoma.
Collegium antropologicum, 2005 Achievement of target intraocular pressure is the goal of every efficient antiglaucoma therapy. Target intraocular pressure is the level of intraocular pressure which is associated with minimal likelihood of visual field or optic nerve lesion, or an existing lesion progression due to elevated intraocular pressure.
Popović-Suić S. +5 more
+8 more sources
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
Frontiers in Medicine, 2022 Glaucoma is the leading cause of irreversible blindness worldwide. Several risk factors have been involved in the pathogenesis of the disease. By now, the main treatable risk factor is elevated intraocular pressure.
Alessio Martucci +5 more
doaj +1 more source